Cathode material and fuel cell
US-2015349349-A1 · Dec 3, 2015 · US
US10297835B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10297835-B2 |
| Application number | US-201414278478-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 15, 2014 |
| Priority date | May 17, 2013 |
| Publication date | May 21, 2019 |
| Grant date | May 21, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A glucose fuel cell for reception into a given constrained volume of implantation in a vertebrate in which the glucose fuel cell has access to fluid containing glucose. The fuel cell includes an anode adapted to oxidize the glucose, a cathode adapted to reduce an oxidant, and a membrane disposed between the anode and the cathode and separating the anode from the cathode. At least one of the anode or cathode define a flexible sheet that is geometrically deformed to be receivable into the given constrained volume of implantation and increase volumetric power density. Related methods of making a glucose fuel cell of this type and implantable assemblies including the glucose fuel cell are also disclosed.
Opening claim text (preview).
What is claimed is: 1. An enzyme-free, fully implantable glucose fuel cell for reception into a given constrained volume of implantation in a vertebrate in which the glucose fuel cell has access to fluid including glucose and dissolved fluidic oxygen, the fuel cell comprising: an anode adapted to oxidize the glucose with no biological enzymes or biological catalysts; a cathode adapted to reduce an oxidant with no biological enzymes or biological catalysts; and a membrane disposed between the anode and the cathode and separating the anode from the cathode; wherein the fuel cell is in the form of a flexible sheet that is geometrically deformed into a coiled or spiral shape receivable into the given constrained volume of implantation and wherein the flexibility is exploited to improve volumetric power density; and wherein the flexible sheet includes openings from one side of the flexible sheet to the other side of the flexible sheet that accommodate fluid flow of fluid containing dissolved glucose and dissolved fluidic oxygen from one side of the flexible sheet to the other side of the flexible sheet to increase overall availability of dissolved glucose and dissolved fluidic oxygen to the anode and cathode, respectively, and to allow either or both dissolved glucose and dissolved oxygen radial access between multiple coiled layers of the flexible sheet. 2. The glucose fuel cell of claim 1 , wherein the flexible sheet further comprises a flexible mechanical substrate on which the anode, the cathode, and the membrane reside. 3. The glucose fuel cell of claim 2 , wherein the flexible sheet is approximately 7 μm thick. 4. The glucose fuel cell of claim 2 , wherein the flexible mechanical substrate is an oxide layer. 5. The glucose fuel cell of claim 1 , wherein the flexible sheet is rolled such that the glucose fuel cell has a rolled-up form factor. 6. The glucose fuel cell of claim 1 , wherein, as the flexible shape is deformed into a shape, the volumetric power density of the fuel cell is increased. 7. The glucose fuel cell of claim 1 , wherein the anode is nanoporous platinum or platinized platinum, the cathode is a sulfonated tetrafluoroethylene-based fluoropolymer-copolymer having single-walled carbon nanotubes embedded therein, and the membrane is a sulfonated tetrafluoroethylene-based fluoropolymer-copolymer. 8. The glucose fuel cell of claim 1 , wherein the oxidant is another carbohydrate or organic fuel. 9. The glucose fuel cell of claim 1 , wherein a given constrained volume of implantation is a subcutaneous reservoir with access to cerebrospinal fluid in at least one of the brain and spinal cord of the vertebrate. 10. The glucose fuel cell of claim 1 , wherein the fuel cell is used to sense glucose. 11. An implantable assembly comprising the glucose fuel cell of claim 1 and electronics powered by the glucose fuel cell, wherein the glucose fuel cell is co-fabricated with at least a portion of the electronics on a flexible mechanical substrate with semiconductor fabrication techniques that are common to both the electronics and to the glucose fuel cell. 12. The implantable assembly of claim 11 , wherein the glucose fuel cell provides at least one of power and glucose-sensing inputs to a medical device. 13. The implantable assembly of claim 12 , wherein the medical device is implanted alongside the glucose fuel cell. 14. The implantable assembly of claim 12 , wherein the medical device is implanted within the vertebrate at a location remote from a location of implantation of the glucose fuel cell.
Fuel cells applied on a support, e.g. miniature fuel cells deposited on silica supports · CPC title
Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence) · CPC title
Micromachining techniques, e.g. masking, etching steps or photolithography · CPC title
Alloys or mixtures with metallic elements · CPC title
generated by biological activity or substance, e.g. body movement · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.